Identification of novel dihydroorotate dehydrogenase (DHODH) inhibitors for cancer: computational drug repurposing strategy

Authors

Institutions

Publication Details

Journal
BMC Pharmacology and Toxicology
Published
2025-10-22
DOI
https://doi.org/10.1186/s40360-025-01007-w
Primary Topic
Biochemical and Molecular Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of novel dihydroorotate dehydrogenase (DHODH) inhibitors for cancer: computational drug repurposing strategy

V. Shanthi, Rahamathtunnisa Rajamohamed
BMC Pharmacology and Toxicology
Biochemical and Molecular Research
article

Identification of novel dihydroorotate dehydrogenase (DHODH) inhibitors for cancer: computational drug repurposing strategy

V. Shanthi, Rahamathtunnisa Rajamohamed
article en

Abstract

No abstract available for this paper.
BMC Pharmacology and ToxicologyVol. 26(1)
Vellore Institute of Technology University (IN)
VIT University
Openalex Percentile: Top 73%
Biochemical and Molecular Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Identification of novel dihydroorotate dehydrogenase (DHODH) inhibitors for cancer: computational drug repurposing strategy — V. Shanthi, Rahamathtunnisa Rajamohamed · BMC Pharmacology and Toxicology (2025) | TGRS Research Map | TGRS